Selank 10MG

Selank is a synthetic heptapeptide analog of tuftsin, an immunomodulatory tetrapeptide fragment of immunoglobulin G. Developed by Russian researchers seeking an anxiolytic agent without the sedative burden of classical tranquilizers, Selank incorporates a Pro-Gly-Pro C-terminal extension that confers resistance to enzymatic degradation. In preclinical models it has been studied for its interactions with GABAergic signaling, brain-derived neurotrophic factor expression, and immune-cell modulation — reflecting tuftsin's dual heritage in both neural and immune biology. The compound occupies a distinctive niche in the nootropic-peptide literature, where it is compared against Semax and other regulatory peptides in behavioral assays, gene-expression studies, and neurochemical profiling. Its heptapeptide length keeps synthesis and analytical verification straightforward, supporting reproducible research use. This 10MG lyophilized presentation is the conventional format for neurotropic peptide research. Its dual activity profile — spanning neural and immune readouts — makes Selank a recurring subject in psychoneuroimmunology-oriented peptide research. For laboratory research use only. Not for human or veterinary use.